Literature DB >> 23867241

Research advances on the usage of traditional Chinese medicine for neuroprotection in glaucoma.

Xue-song Mi1, Jing-xiang Zhong, Raymond Chuen-Chung Chang, Kwok-Fai So.   

Abstract

Progressive loss of retinal ganglion cells (RGCs) and their axons is the main pathogenesis of glaucoma. The cause of glaucoma is not fully understood, but the neurodegeneration of glaucoma involves many mechanisms such as oxidative stress, glutamate toxicity and ischemia/reperfusion insult. In order to target these mechanisms, multiple neuroprotective interventions have been investigated to prevent the death of RGCs. Of note are some tonic herbs from the traditional Chinese medicine (TCM) pharmacopeia that have shown neuroprotective effects in glaucoma. TCM differs from Western medicine in that TCM exhibits complicated bioactive components, triggering many signaling pathways and extensive actions on vital organs. Modern scientific approaches have demonstrated some of their underlying mechanisms. In this review, we used Lycium barbarum and Ginkgo biloba as examples to elaborate the characteristics of TCM and their potential applications in neuroprotection in glaucoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23867241     DOI: 10.3736/jintegrmed2013037

Source DB:  PubMed          Journal:  J Integr Med


  12 in total

1.  Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats.

Authors:  Rong Wang; Hai Zhang; Sen Sun; Yuanyuan Wang; Yifeng Chai; Yongfang Yuan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

2.  Salvia miltiorrhiza extracts protect against retinal injury in a rat glaucoma model.

Authors:  Qi Zhu; Guanfang Su; Lili Nie; Chenguang Wang; Yuxi He; Xin Liu
Journal:  Exp Ther Med       Date:  2014-03-24       Impact factor: 2.447

3.  Protective effect of tea polyphenol ophthalmic gel on lens epithelial cells in rabbits with silicone oil tamponade after vitrectomy.

Authors:  Xianzhen Ma; Dadong Guo; Hongsheng Bi; Xiaofeng Xie; Junguo Guo; Yan Cui
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-20       Impact factor: 2.629

4.  Retinal structure and function preservation by polysaccharides of wolfberry in a mouse model of retinal degeneration.

Authors:  Ke Wang; Jia Xiao; Bo Peng; Feiyue Xing; Kwok-Fai So; George L Tipoe; Bin Lin
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

5.  Protection of Tong-Sai-Mai Decoction against Apoptosis Induced by H2O2 in PC12 Cells: Mechanisms via Bcl-2-Mitochondria-ROS-INOS Pathway.

Authors:  Maxwell Kim Kit Lee; Yin Lu; Liu-Qing Di; Hui-Qin Xu
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-22       Impact factor: 2.629

6.  Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure.

Authors:  Dorota Szumny; Tomasz Sozański; Alicja Z Kucharska; Wojciech Dziewiszek; Narcyz Piórecki; Jan Magdalan; Ewa Chlebda-Sieragowska; Robert Kupczynski; Adam Szeląg; Antoni Szumny
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-01       Impact factor: 2.629

7.  A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma.

Authors:  Li Chao; Lu Na; Li Bin; Zheng Botao; Li Shuaijie
Journal:  Open Med (Wars)       Date:  2016-02-22

8.  Effect of topical application of adrenaline on Schlemm canal, trabecular meshwork and intraocular pressure.

Authors:  Meng Ye; Zhiqi Chen; Mu Li; Wei Chen; Hong Zhang; Junming Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 9.  Mechanisms of secondary degeneration after partial optic nerve transection.

Authors:  Hong-Ying Li; Yi-Wen Ruan; Chao-Ran Ren; Qi Cui; Kwok-Fai So
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

Review 10.  Complementary and Alternate Management of Glaucoma: The Verdict so Far.

Authors:  Shibal Bhartiya; Parul Ichhpujani
Journal:  J Curr Glaucoma Pract       Date:  2014-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.